GRCL

Gracell Biotechnologies Inc

1 day chart

About GRCL

Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric antigen receptor (CAR) thymus (T) cell therapies by leveraging its technology platforms FasTCAR and TruUCAR. With FasTCAR, the Company is able to deliver younger, less exhausted T cells for autologous cell therapies with enhanced activities and next-day manufacturing. With TruUCAR, the Company is able derive T cells from non-human leukocyte antigen (HLA)-matched healthy donors to generate allogeneic CAR-T cell therapies. The Company is levering its technology platform to develop various drug candidates, including GC012F, GC019F, GC007F, GC027 and GC007g.

Buy US stocks in Australia starting with GRCL. Open an account and start investing today!

Market Capitalisation

$467.16M

Price-earnings ratio

Dividend yield

0.00%

Volume

257.13K

High today

$5.31

Low today

$4.77

Open price

$4.88

52-week high

$6.99

52-week low

$1.40

GRCL FAQs

Can I buy GRCL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy GRCL shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Gracell Biotechnologies Inc?

One share of Gracell Biotechnologies Inc is valued at $5.25.

What is the ticker symbol for Gracell Biotechnologies Inc?

The ticker symbol for Gracell Biotechnologies Inc is GRCL.

How do I buy GRCL shares in Australia?

To buy GRCL stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in GRCL

What is the 52-week high for Gracell Biotechnologies Inc stock?

The Gracell Biotechnologies Inc 52-week high stock price is $6.99.

What is the 52-week low for Gracell Biotechnologies Inc stock?

The Gracell Biotechnologies Inc 52-week low stock price is $1.40.

What is the market capitalisation of Gracell Biotechnologies Inc GRCL?

As of 02/12/2023 Gracell Biotechnologies Inc has a market cap of $467M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.